JUNB- and NPM1-ALK-mediated GZMB gene expression

Stable Identifier
R-HSA-9851088
Type
Reaction [omitted]
Species
Homo sapiens
Compartment
nucleoplasm, cytolytic granule lumen
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
JUNB- and NPM1-ALK-mediated GZMB gene expression
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Granzyme B (GZMB) is a member of a family of 5 cytotoxic GZMB protein that contribute to cell death in response to cancer and infection (reviewed in Arias et al, 2017; Tibbs and Cao, 2022). GZMB is expressed in NPM1-ALK cells in a manner that depends on JUNB binding to cognate sites in its promoter (Pearson et al, 2011).
Literature References
PubMed ID Title Journal Year
35326588 Emerging Canonical and Non-Canonical Roles of Granzyme B in Health and Disease

Tibbs, E, Cao, X

Cancers (Basel) 2022
21326808 NPM-ALK and the JunB transcription factor regulate the expression of cytotoxic molecules in ALK-positive, anaplastic large cell lymphoma

Ingham, RJ, Bacani, JT, Lai, R, Pearson, JD, Lee, JK

Int J Clin Exp Pathol 2011
28718416 The Untold Story of Granzymes in Oncoimmunology: Novel Opportunities with Old Acquaintances

Ferrandez, A, Santiago, L, Pardo, J, Granville, DJ, Arias, M, Martínez-Lostao, L

Trends Cancer 2017
Participants
Input
Output
Participates
as an event of
This event is regulated
Positively by
Regulator
GZMB gene:JUNB dimer [nucleoplasm] (Homo sapiens)
Active Unit
JUNB [nucleoplasm]
Disease
Authored
Rothfels, K  (2023-10-14)
Reviewed
Turner, S  (2023-11-08)
Created
Rothfels, K  (2023-10-12)
Cite Us!